Frontiers in Pharmacology

Liraglutide and renal mitochondrial homeostasis: targeting the "metabolism-inflammation-lithogenesis" axis in metabolic syndrome

By Fei Wang, Qiuyu Li, Quan Wen, Qiqi He

ReviewInterventions

The paper

Fei Wang, Qiuyu Li, Quan Wen, Qiqi He

Lanzhou University Second Hospital

Frontiers in Pharmacology, 4 Sep 2026

doi.org/10.3389/fphar.2026.1903973 PubMed 42761830

Nature Medicine4 Oct 2026
Semaglutide may protect kidneys by reducing vascular resistance
Diabetes, Obesity & Metabolism4 Oct 2026
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Research Square8 Oct 2026
Semaglutide improved heart artery function in pigs
Clinical Journal of the American Society of Nephrology4 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes